ArticleOncotarget2017

The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.

Puyuan Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.